Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.
Saved in:
| Title: | Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma. |
|---|---|
| Authors: | Shi W; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Xu-Monette ZY; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Jia Y; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Tzankov A; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Go H; Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea., Li L; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Ponzoni M; San Raffaele H. Scientific Institute, Milan, Italy., Wang Y; Institute of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Zhai Q; Institute of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Perry AM; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Wang S; Department of Pathology, National University Hospital, Singapore, Singapore., Wang X; Sun Yat-Sen University Cancer Center, Guangzhou, China., Chiu A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Xu ML; Department of Pathology and Laboratory Medicine, Yale University Medical Center, New Haven, CT, USA., Visco C; Department of Engineering of Innovative Medicine, University of Verona, Verona, Italy., Dybkaer K; Aalborg University Hospital, Aalborg, Denmark., Withers H; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Long M; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Yuan AF; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Miao Y; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Macias E; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Wu D; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Shuai W; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Wang B; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Li J; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Bhagat G; Department of Pathology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA., Zu Y; Department of Pathology, Houston Methodist Hospital, Houston, TX, USA., Pan Z; Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA., Choi W; Department of Pathology, Victoria Hospital, Hong Kong, China., Montes-Moreno S; Translational Hematopathology Laboratory and Anatomic Pathology Service, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain., Chen W; Department of Pathology, University of Texas Southwest Medical Center, Dallas, TX, USA., Krieken JHV; Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands., Møller MB; Odense University Hospital, Odense, Denmark., Yu X; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Parsons BM; Gundersen Lutheran Health System, La Crosse, WI, USA., Zhang S; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, NE, USA., Hsi ED; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Sohani AR; Massachussett General Hospital, Center for Lymphoma, Harvard Medical School, Boston, MA, USA., Abramson JS; Massachussett General Hospital, Center for Lymphoma, Harvard Medical School, Boston, MA, USA., Ferreri AJM; San Raffaele H. Scientific Institute, Milan, Italy., Xu B; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Li Y; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Young KH; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA. ken.young@duke.edu.; Duke Cancer Institute, Durham, NC, USA. ken.young@duke.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Jul 17; Vol. 15 (1), pp. 123. Date of Electronic Publication: 2025 Jul 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
